Effects of weekly or daily exposure to the elevated plus-maze in male mice

Behavioural Brain Research

Volumn 87, Issue 2, 1997, Pages 233-238

  Espejo, Emilio Fdez ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Anxiety; Elevated plus maze; Mouse; Response selection

Indexed keywords

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; HABITUATION; LOCOMOTION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANXIETY; AROUSAL; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MAZE LEARNING; MENTAL RECALL; MICE; MOTOR ACTIVITY;

EID: 0030763281     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)02286-9     Document Type: Article

References (28)

1. Blanchard, R.J. and Blanchard, D.C., Attack and defense in rodents as ethoexperimental models for the study of emotion. Progr. Neuro-Psychopharmacol. Biol. Psych., 13 (1989) S3-S14.
2. Claus, H.J. and Bindra, D., Reactions to novelty and stimulus-change induced response decrement, Can. J. Psychol., 14 (1960) 101-110.
3. Colgan, P.W., Quantitative Ethology, 1978, Wiley, New York.
4. Cruz, A.P., Frei, F. and Graeff, F.G., Ethopharmacological analysis of rat behaviour on the elevated plus-maze, Pharmacol. Biochem. Behav., 49 (1994) 171-176.
5. Dawson G.R., Crawford, S.P., Stanhope, K.J., Iversen, S.D. and Tricklebank, M.D., One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure, Psychopharmacology, 113 (1994) 570-572.
6. Espejo, E.F., Structure of the mouse behaviour on the elevated plus-maze test of anxiety, Behav. Brain Res., (1997) in press.
7. File, S.E., One-trial tolerance to anxiolytic actions of chlordiazepoxide in the plus-maze, Psychopharmacology, 100 (1990) 281-282.
8. File, S.E., Behavioral detection of anxiolytic action. In J.M. Elliott, D.J. Heal and C.A. Marsden (Eds.) Experimental Approaches to Anxiety and Depression, 1992, Wiley, Chichester, pp. 25-44.
9. Handley, S.L. and Mithani, S., Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch. Pharmacol., 327 (1984) 1-5.
10. Kaesermann, H.P., Stretched attended posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action, Psychopharmacology, 89 (1986) 31-37.
11. Lee, C. and Rodgers, R.J., Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulation, Psychopharmacology, 102 (1990) 507-513.
12. Lister, R.G., The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology, 92 (1987) 180-185.
13. Lister, R.G., Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety, Pharmacol. Biochem. Behav., 30 (1988) 701-706.
14. A and 5-HT anxiolytics, Psychopharmacology, 121 (1995) 38-56.
15. Molewijk, H.E., van der Poel, A.M. and Olivier, B., The ambivalent behavior 'stretched approach posture' in the rat as a paradigm to characterize anxiolytic drugs, Psychopharmacology, 121 (1995) 81-90.
16. Montgomery, K.C., The relationship between fear induced by novel stimulation and exploratory behaviour, J. Comp. Physiol. Psychol., 48 (1955) 254-260.
17. Moser, P.C., An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone, Psychopharmacology, 99 (1989) 48-53.
18. Motta, V. and Brandao, M.L., Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze, Pharmacol. Biochem. Behav., 44 (1993) 119-125.
19. Pellow, S., Chopin, P., File, S.E. and Briley, M., Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Meth., 14 (1985) 149-167.
20. Rodgers, R.J., A step in the right direction, J. Psychopharmacol., 5 (1991) 316-319.
21. Rodgers, R.J., Cole, J.C., Cobain, M.R., Daly, P., Doran, P.J., Eells, J.R. and Wallis, P., Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP, Behav. Pharmacol., 3 (1992) 621-634.
22. Rodgers, R.J. and Cole, J.C., The elevated plus-maze: pharmacology, methodology and ethology. In S.J. Cooper and C.A. Hendrie (Eds.) Ethology and Psychopharmacology, 1994, Wiley, New York, pp. 9-44.
23. Rodgers, R.J. and Johnson, N.J.T., Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety, Pharmacol. Biochem. Behav., 52 (1996) 297-303.
24. Shepherd, J.K., Preliminary evaluation of an elevated 'zero-maze' as a model of anxiety in laboratory rats, Br. J. Pharmacol., 110 (1994) 13P.
25. Slater, P.J.B., Data collection. In P.W. Colgan (Ed.), Quantitative Ethology, 1978, Wiley, New York, pp. 7-24.
26. Treit, D., Menard, J. and Royan, C., Anxiogenic stimuli in the elevated plus-maze, Pharmacol. Biochem. Behav., 44 (1993) 463-469.
27. Trullas, R. and Skolnick, P., Differences in fear motivated behaviours among inbred mouse strains, Psychopharmacology, 111 (1993) 323-331.
28. Wada, T. and Fukuda, N., Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in the elevated plus-maze, Psychopharmacology, 104 (1991) 444-450.